Home Gilead clears European hurdle for next-generation hepatitis C drug
 

Keywords :   


Gilead clears European hurdle for next-generation hepatitis C drug

2014-09-27 18:48:59| Biotech - Topix.net

The European Commission will weigh the positive recommendation by the Committee for Medicinal Products for Human Use, or CHMP, as it considers whether Harvoni - a combination of Gilead's Sovaldi and its experimental drug ledipasvir - can be sold in 28 European countries. The move comes as the Food and Drug Administration ways approval of the drug, which Foster City-based Gilead has hinted could cost under $100,000 .

Tags: drug european hepatitis clears

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »